In an eventful year, Makary hasn’t faced Congressional scrutiny

As Marty Makary approaches his first anniversary as FDA commissioner on March 28, after one of the most eventful years in the agency’s history, he has spoken frequently in public while largely avoiding situations where he might be required to defend or explain his actions.

Few public forums are more stressful or more revealing for government officials than congressional hearings. Witnesses testify under oath and face questioning from lawmakers who may be hostile, skeptical, or eager to expose weaknesses in the official’s record...